- Home
- CTMX vs RRGB Comparison
CTMX vs RRGB Comparison
Compare CTMX & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- RRGB
- Stock Information
- Founded
- CTMX 2008
- RRGB 1969
- Country
- CTMX United States
- RRGB United States
- Employees
- CTMX N/A
- RRGB N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- RRGB Restaurants
- Sector
- CTMX Health Care
- RRGB Consumer Discretionary
- Exchange
- CTMX Nasdaq
- RRGB Nasdaq
- Market Cap
- CTMX 349.6M
- RRGB 88.7M
- IPO Year
- CTMX 2015
- RRGB 2002
- Fundamental
- Price
- CTMX $1.98
- RRGB $6.65
- Analyst Decision
- CTMX Strong Buy
- RRGB Strong Buy
- Analyst Count
- CTMX 4
- RRGB 2
- Target Price
- CTMX $5.13
- RRGB $11.00
- AVG Volume (30 Days)
- CTMX 2.4M
- RRGB 250.8K
- Earning Date
- CTMX 11-06-2025
- RRGB 11-05-2025
- Dividend Yield
- CTMX N/A
- RRGB N/A
- EPS Growth
- CTMX 263.20
- RRGB N/A
- EPS
- CTMX 0.49
- RRGB N/A
- Revenue
- CTMX $141,100,000.00
- RRGB $1,235,920,000.00
- Revenue This Year
- CTMX N/A
- RRGB N/A
- Revenue Next Year
- CTMX N/A
- RRGB N/A
- P/E Ratio
- CTMX $3.98
- RRGB N/A
- Revenue Growth
- CTMX 18.01
- RRGB N/A
- 52 Week Low
- CTMX $0.40
- RRGB $2.50
- 52 Week High
- CTMX $3.10
- RRGB $7.89
- Technical
- Relative Strength Index (RSI)
- CTMX 44.12
- RRGB 56.15
- Support Level
- CTMX $1.90
- RRGB $6.60
- Resistance Level
- CTMX $2.03
- RRGB $7.01
- Average True Range (ATR)
- CTMX 0.12
- RRGB 0.28
- MACD
- CTMX -0.01
- RRGB 0.03
- Stochastic Oscillator
- CTMX 18.75
- RRGB 65.05
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.